论文部分内容阅读
Lowered testosterone in male obesity: mechanisms,morbidity and management
【机 构】
：
Department of Medicine Austin Health, University of Melbourne, Melbourne ; Department of Endocrinolo
【出 处】
：
亚洲男性学杂志（英文版）
【发表日期】
：
2014年2期
其他文献
Gene-environment interactions in male reproductive health: special reference to the aryl hydrocarbon
It is well?documented that male overweight and obesity causes endocrine disorders that might diminish the male reproductive capacity; however, reports have been conlficting regarding the inlfuence of male body mass index(BMI) on semen quality and the outc
Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial o
Prostatecancer is aleading cause of cancer death in men.Despite recent advances in our understanding and treatment of advanced disease,no systemic therapy is curative and new therapies are needed.Targeting angiogenesis is an attractive therapeutic strateg
期刊
The introduction of nerve-sparing technique is one of the most significant advances in the surgical treatment of prostate cancer and heralded a shift from a curing cancer at all-cost model to a curing cancer and preserving quality of life model?,2 In a re
期刊
PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5-10.
11β-hydroxysteroid dehydrogenase types 1 and 2 in postnatal development of rat testis: gene expressi
In 2004, docetaxel was approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC). For the next several years, there was a lull in drug approvals. However, from 2010 onwards, 5 additional therapies have been approved on the basi